Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma

Clinical trial NCT05618925 · RECRUITING

Trial details

NCT number: NCT05618925
Sponsor: ImmunityBio, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin's Lymphoma Refractory/Relapsed

Start date: 2025-08-22
Primary completion: 2026-05-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.